76 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35115900 | Celecoxib-Induced Modulation of Colon Cancer CD133 Expression Occurs through AKT Inhibition and Is Monitored by 89Zr Immuno-PET. | 2022 | 3 |
2 | 35176901 | Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity and EMT Inhibition Via AKT and ERK Pathways in Human Urothelial Carcinoma. | 2022 Jan-Dec | 2 |
3 | 33489855 | Celecoxib induces apoptosis through Akt inhibition in 5-fluorouracil-resistant gastric cancer cells. | 2021 Jan | 2 |
4 | 32208383 | Aberrant cell migration contributes to defective airway epithelial repair in childhood wheeze. | 2020 Apr 9 | 1 |
5 | 32705218 | Potentiation of TRAIL‑induced cell death by nonsteroidal anti‑inflammatory drug in human hepatocellular carcinoma cells through the ER stress‑dependent autophagy pathway. | 2020 Sep | 1 |
6 | 33019464 | The molecular mechanisms of celecoxib in tumor development. | 2020 Oct 2 | 1 |
7 | 31613929 | Celecoxib enhances the sensitivity of non-small-cell lung cancer cells to radiation-induced apoptosis through downregulation of the Akt/mTOR signaling pathway and COX-2 expression. | 2019 | 3 |
8 | 29541415 | Sensitization of multidrug-resistant cancer cells to Hsp90 inhibitors by NSAIDs-induced apoptotic and autophagic cell death. | 2018 Feb 16 | 1 |
9 | 29593389 | Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells. | 2018 | 1 |
10 | 30326204 | The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategy. | 2018 Dec | 1 |
11 | 27666139 | Celecoxib enhances the inhibitory effect of 5-FU on human squamous cell carcinoma proliferation by ROS production. | 2017 Apr | 1 |
12 | 28053596 | Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway. | 2017 | 3 |
13 | 28283800 | Blocking COX-2 induces apoptosis and inhibits cell proliferation via the Akt/survivin- and Akt/ID3 pathway in low-grade-glioma. | 2017 Apr | 2 |
14 | 28804691 | Combination of celecoxib (Celebrex®) and CD19 CAR-redirected CTL immunotherapy for the treatment of B-cell non-Hodgkin's lymphomas. | 2017 | 1 |
15 | 29048666 | Synergistic antitumor effects of the combined treatment with an HDAC6 inhibitor and a COX-2 inhibitor through activation of PTEN. | 2017 Nov | 3 |
16 | 29216640 | Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells. | 2017 | 3 |
17 | 26899878 | Comparative Proteomic Study of Fatty Acid-treated Myoblasts Reveals Role of Cox-2 in Palmitate-induced Insulin Resistance. | 2016 Feb 22 | 1 |
18 | 27835884 | Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer. | 2016 Dec 20 | 1 |
19 | 25701378 | Celecoxib sensitizes gastric cancer to rapamycin via inhibition of the Cbl-b-regulated PI3K/Akt pathway. | 2015 Jul | 5 |
20 | 25770423 | Activating PTEN by COX-2 inhibitors antagonizes radiation-induced AKT activation contributing to radiosensitization. | 2015 May 1 | 2 |
21 | 25851346 | Synergistic effect between celecoxib and luteolin is dependent on estrogen receptor in human breast cancer cells. | 2015 Aug | 2 |
22 | 25964548 | Combining CAL-101 with Celecoxib Enhances Apoptosis of EBV-transformed B-Cells Through MAPK-induced ER Stress. | 2015 May | 1 |
23 | 26225471 | The interplay between GRP78 expression and Akt activation in human colon cancer cells under celecoxib treatment. | 2015 Oct | 2 |
24 | 24520227 | Synergistic Effect of COX-2 Inhibitor on Paclitaxel-Induced Apoptosis in the Human Ovarian Cancer Cell Line OVCAR-3. | 2014 Jan | 1 |
25 | 24676394 | Celecoxib regulates apoptosis and autophagy via the PI3K/Akt signaling pathway in SGC-7901 gastric cancer cells. | 2014 Jun | 4 |
26 | 24855827 | Anticancer effects of celecoxib through inhibiton of STAT3 phosphorylation and AKT phosphorylation in nasopharyngeal carcinoma cell lines. | 2014 May | 2 |
27 | 25107843 | The PI3K/Akt pathway in colitis associated colon cancer and its chemoprevention with celecoxib, a Cox-2 selective inhibitor. | 2014 Jul | 1 |
28 | 23229294 | Synergistic apoptotic effect of celecoxib and luteolin on breast cancer cells. | 2013 Feb | 1 |
29 | 23524145 | Enhanced apoptotic effects by downregulating Mcl-1: evidence for the improvement of photodynamic therapy with Celecoxib. | 2013 Jun 10 | 1 |
30 | 23564777 | Combining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitro. | 2013 Apr | 1 |
31 | 23679684 | Effects of celecoxib treatment over the AKT pathway in head and neck squamous cell carcinoma. | 2013 Nov | 2 |
32 | 23833672 | Celecoxib inhibits insulin-like growth factor 1 induced growth and invasion in non-small cell lung cancer. | 2013 Jun | 2 |
33 | 22546756 | Cyclooxygenase-2 inhibitors induce anoikis in osteosarcoma via PI3K/Akt pathway. | 2012 Jul | 1 |
34 | 21430081 | Celecoxib and 2,5-dimethyl-celecoxib prevent cardiac remodeling inhibiting Akt-mediated signal transduction in an inherited dilated cardiomyopathy mouse model. | 2011 Jul | 1 |
35 | 21807123 | The acid sphingomyelinase inhibitors block interferon-α-induced serotonin uptake via a COX-2/Akt/ERK/STAT-dependent pathway in T cells. | 2011 Nov | 1 |
36 | 21868755 | Celecoxib promotes c-FLIP degradation through Akt-independent inhibition of GSK3. | 2011 Oct 1 | 3 |
37 | 19954924 | Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling. | 2010 May | 2 |
38 | 20083195 | Celecoxib activates PI-3K/Akt and mitochondrial redox signaling to enhance heme oxygenase-1-mediated anti-inflammatory activity in vascular endothelium. | 2010 Apr 15 | 3 |
39 | 20578837 | Activated PI3K/Akt/COX-2 pathway induces resistance to radiation in human cervical cancer HeLa cells. | 2010 Jun | 1 |
40 | 20664740 | Celecoxib does not attenuate the antiplatelet effects of aspirin and clopidogrel in healthy volunteers. | 2010 Jul | 1 |
41 | 20926014 | Combined inhibitory effects of celecoxib and fluvastatin on the growth of human hepatocellular carcinoma xenografts in nude mice. | 2010 Jul-Aug | 2 |
42 | 18506760 | Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib. | 2009 Jan | 1 |
43 | 18823436 | Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling. | 2009 Mar | 2 |
44 | 19558494 | Inhibition of 12-LOX and COX-2 reduces the proliferation of human epidermoid carcinoma cells (A431) by modulating the ERK and PI3K-Akt signalling pathways. | 2009 Nov | 1 |
45 | 19787257 | Synergistic effects of lovastatin and celecoxib on caveolin-1 and its down-stream signaling molecules: Implications for colon cancer prevention. | 2009 Nov | 1 |
46 | 21556247 | Effects of celecoxib and ly117018 combination on human breast cancer cells in vitro. | 2009 Apr 7 | 2 |
47 | 18078766 | Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt. | 2008 May | 3 |
48 | 18083230 | Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1. | 2008 Jun | 2 |
49 | 18172786 | Selective COX-2 inhibitor celecoxib combined with EGFR-TKI ZD1839 on non-small cell lung cancer cell lines: in vitro toxicity and mechanism study. | 2008 | 1 |
50 | 18201156 | Celecoxib to prevent restenosis--results from the COREA-TAXUS trial. | 2008 Feb | 2 |